BEAM
Price
$20.17
Change
+$0.59 (+3.01%)
Updated
Jul 16, 04:43 PM (EDT)
Capitalization
1.97B
27 days until earnings call
QURE
Price
$14.43
Change
+$0.47 (+3.37%)
Updated
Jul 16, 04:59 PM (EDT)
Capitalization
764.29M
15 days until earnings call
Interact to see
Advertisement

BEAM vs QURE

Header iconBEAM vs QURE Comparison
Open Charts BEAM vs QUREBanner chart's image
Beam Therapeutics
Price$20.17
Change+$0.59 (+3.01%)
Volume$2.11K
Capitalization1.97B
uniQure
Price$14.43
Change+$0.47 (+3.37%)
Volume$13.21K
Capitalization764.29M
BEAM vs QURE Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. QURE commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and QURE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (BEAM: $19.58 vs. QURE: $13.96)
Brand notoriety: BEAM and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 154% vs. QURE: 71%
Market capitalization -- BEAM: $1.97B vs. QURE: $764.29M
BEAM [@Biotechnology] is valued at $1.97B. QURE’s [@Biotechnology] market capitalization is $764.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and QURE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while QURE’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • QURE’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than QURE.

Price Growth

BEAM (@Biotechnology) experienced а -3.55% price change this week, while QURE (@Biotechnology) price change was -3.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was +38.06%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

QURE is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.97B) has a higher market cap than QURE($764M). QURE (-20.951) and BEAM (-21.048) have similar YTD gains . QURE has higher annual earnings (EBITDA): -138.01M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. QURE (409M). QURE has less debt than BEAM: QURE (66.2M) vs BEAM (158M). BEAM has higher revenues than QURE: BEAM (63.6M) vs QURE (20.2M).
BEAMQUREBEAM / QURE
Capitalization1.97B764M258%
EBITDA-399.03M-138.01M289%
Gain YTD-21.048-20.951100%
P/E RatioN/AN/A-
Revenue63.6M20.2M315%
Total Cash1.22B409M298%
Total Debt158M66.2M239%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMQURE
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
74%
Declines
ODDS (%)
Bearish Trend 24 days ago
85%
Bearish Trend 20 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIADX56.54N/A
N/A
Fidelity Advisor International Discv I
AGIZX82.48N/A
N/A
Alger Growth & Income Z
CDOZX40.16N/A
N/A
Columbia Dividend Opportunity Inst
MXMSX10.90N/A
N/A
Empower Small Cap Growth Instl
PIEFX17.92N/A
N/A
Federated Hermes Emerging Markets Eq IS